Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.2 USD 9.09%
Market Cap: 23m USD

Trinity Biotech PLC
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Trinity Biotech PLC
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Trinity Biotech PLC
NASDAQ:TRIB
Cash from Operating Activities
-$4.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medtronic PLC
NYSE:MDT
Cash from Operating Activities
$7.1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
2%
STERIS plc
NYSE:STE
Cash from Operating Activities
$1.3B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
19%
No Stocks Found

Trinity Biotech PLC
Glance View

Market Cap
23m USD
Industry
Health Care

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

TRIB Intrinsic Value
HIDDEN
Show

See Also

What is Trinity Biotech PLC's Cash from Operating Activities?
Cash from Operating Activities
-4.2m USD

Based on the financial report for Dec 31, 2024, Trinity Biotech PLC's Cash from Operating Activities amounts to -4.2m USD.

What is Trinity Biotech PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
64%

Over the last year, the Cash from Operating Activities growth was 64%.

Back to Top